omics and immunologic approaches to optimizing cure rates in her2-positive breast carcinomas.

Clicks: 197
ID: 225789
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
etagliabue2014frontiersomics Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Elda eTagliabue;Manuela eCampiglio
Journal international journal of heat and technology
Year 2014
DOI
10.3389/fonc.2014.00334
URL
http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00334/full
Keywords
Breast cancer targeted therapy her2 omics Oncology including cancer and carcinogens tumors trastuzumab resistanceneoplasms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.